1. Home
  2. RCKT vs CCIX Comparison

RCKT vs CCIX Comparison

Compare RCKT & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • CCIX
  • Stock Information
  • Founded
  • RCKT 1999
  • CCIX 2023
  • Country
  • RCKT United States
  • CCIX United States
  • Employees
  • RCKT N/A
  • CCIX N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • CCIX
  • Sector
  • RCKT Health Care
  • CCIX
  • Exchange
  • RCKT Nasdaq
  • CCIX Nasdaq
  • Market Cap
  • RCKT 328.6M
  • CCIX 386.8M
  • IPO Year
  • RCKT N/A
  • CCIX 2024
  • Fundamental
  • Price
  • RCKT $3.05
  • CCIX $10.53
  • Analyst Decision
  • RCKT Buy
  • CCIX
  • Analyst Count
  • RCKT 13
  • CCIX 0
  • Target Price
  • RCKT $12.88
  • CCIX N/A
  • AVG Volume (30 Days)
  • RCKT 2.6M
  • CCIX 25.4K
  • Earning Date
  • RCKT 08-07-2025
  • CCIX 01-01-0001
  • Dividend Yield
  • RCKT N/A
  • CCIX N/A
  • EPS Growth
  • RCKT N/A
  • CCIX N/A
  • EPS
  • RCKT N/A
  • CCIX 0.28
  • Revenue
  • RCKT N/A
  • CCIX N/A
  • Revenue This Year
  • RCKT N/A
  • CCIX N/A
  • Revenue Next Year
  • RCKT $591.46
  • CCIX N/A
  • P/E Ratio
  • RCKT N/A
  • CCIX $37.21
  • Revenue Growth
  • RCKT N/A
  • CCIX N/A
  • 52 Week Low
  • RCKT $2.19
  • CCIX $10.00
  • 52 Week High
  • RCKT $22.01
  • CCIX $11.66
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 49.19
  • CCIX N/A
  • Support Level
  • RCKT $2.83
  • CCIX N/A
  • Resistance Level
  • RCKT $3.22
  • CCIX N/A
  • Average True Range (ATR)
  • RCKT 0.17
  • CCIX 0.00
  • MACD
  • RCKT 0.01
  • CCIX 0.00
  • Stochastic Oscillator
  • RCKT 41.51
  • CCIX 0.00

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About CCIX Churchill Capital Corp IX Ordinary Shares

Churchill Capital Corp IX is a blank check company.

Share on Social Networks: